CRSP
CRISPR Therapeutics AGNASDAQHealthcare$49.51+1.43%ClosedMarket Cap: $4.75B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
23
Sales
35
Buy/Sell Ratio
0.66
Total Bought
$0.00
Total Sold
$19.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Mar 24 | KASINGER JAMES R. | officer: General Counsel and Secretary | Sell | 6,250 | $0.00 | 97,490 |
| Tue Mar 24 | KASINGER JAMES R. | officer: General Counsel and Secretary | Sell | 3,182 | $46.78 | 94,308 |
| Tue Mar 24 | KASINGER JAMES R. | officer: General Counsel and Secretary | Sell | 38,499 | $46.24 | 38,499 |
| Tue Mar 24 | KASINGER JAMES R. | officer: General Counsel and Secretary | Sell | 25,000 | $0.00 | 25,000 |
| Tue Mar 24 | Kulkarni Samarth | director, officer: Chief Executive Officer | Sell | 19,687 | $0.00 | 265,521 |
| Tue Mar 24 | Kulkarni Samarth | director, officer: Chief Executive Officer | Sell | 10,020 | $46.78 | 255,501 |
| Tue Mar 24 | Kulkarni Samarth | director, officer: Chief Executive Officer | Sell | 114,249 | $46.24 | 114,249 |
| Tue Mar 24 | Kulkarni Samarth | director, officer: Chief Executive Officer | Sell | 81,875 | $0.00 | 81,875 |